152 related articles for article (PubMed ID: 9504468)
1. White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy.
Brown MS; Stemmer SM; Simon JH; Stears JC; Jones RB; Cagnoni PJ; Sheeder JL
AJNR Am J Neuroradiol; 1998 Feb; 19(2):217-21. PubMed ID: 9504468
[TBL] [Abstract][Full Text] [Related]
2. MR and proton spectroscopy of white matter disease induced by high-dose chemotherapy with bone marrow transplant in advanced breast carcinoma.
Brown MS; Simon JH; Stemmer SM; Stears JC; Scherzinger A; Cagnoni PJ; Jones RB
AJNR Am J Neuroradiol; 1995; 16(10):2013-20. PubMed ID: 8585489
[TBL] [Abstract][Full Text] [Related]
3. White matter changes in patients with breast cancer treated with high-dose chemotherapy and autologous bone marrow support.
Stemmer SM; Stears JC; Burton BS; Jones RB; Simon JH
AJNR Am J Neuroradiol; 1994 Aug; 15(7):1267-73. PubMed ID: 7976937
[TBL] [Abstract][Full Text] [Related]
4. Food for thought in a small package.
Ball WS
AJNR Am J Neuroradiol; 1998 Feb; 19(2):395-6. PubMed ID: 9504504
[No Abstract] [Full Text] [Related]
5. High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancer.
Cagnoni PJ; Nieto Y; Shpall EJ; Bearman SI; Barón AE; Ross M; Matthes S; Dunbar SE; Jones RB
J Clin Oncol; 1998 May; 16(5):1661-8. PubMed ID: 9586876
[TBL] [Abstract][Full Text] [Related]
6. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging.
de Ruiter MB; Reneman L; Boogerd W; Veltman DJ; Caan M; Douaud G; Lavini C; Linn SC; Boven E; van Dam FS; Schagen SB
Hum Brain Mapp; 2012 Dec; 33(12):2971-83. PubMed ID: 22095746
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
8. High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer.
Somlo G; Doroshow JH; Forman SJ; Leong LA; Margolin KA; Morgan RJ; Raschko JW; Akman SA; Ahn C; Sniecinski I
Cancer; 1994 Jan; 73(1):125-34. PubMed ID: 7903906
[TBL] [Abstract][Full Text] [Related]
9. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
Klein JL; Rey PM; Dansey RD; Karanes C; Du W; Abella E; Cassells L; Hamm C; Peters WP; Baynes RD
Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864
[TBL] [Abstract][Full Text] [Related]
10. Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13.
Peters WP; Rosner GL; Vredenburgh JJ; Shpall EJ; Crump M; Richardson PG; Schuster MW; Marks LB; Cirrincione C; Norton L; Henderson IC; Schilsky RL; Hurd DD
J Clin Oncol; 2005 Apr; 23(10):2191-200. PubMed ID: 15767638
[TBL] [Abstract][Full Text] [Related]
11. [Brain metabolic disorders after chemotherapy in the study by magnetic resonance spectroscopy].
Ciszkowska-Łysoń B; Królicki L; Teska A; Janowicz-Zebrowska A; Krzakowski M; Tacikowska M
Neurol Neurochir Pol; 2003; 37(4):783-98. PubMed ID: 14746239
[TBL] [Abstract][Full Text] [Related]
12. High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy.
Reece DE; Barnett MJ; Shepherd JD; Hogge DE; Klasa RJ; Nantel SH; Sutherland HJ; Klingemann HG; Fairey RN; Voss NJ
Blood; 1995 Jul; 86(2):451-6. PubMed ID: 7541661
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment.
Chap L; Shpiner R; Levine M; Norton L; Lill M; Glaspy J
Bone Marrow Transplant; 1997 Dec; 20(12):1063-7. PubMed ID: 9466279
[TBL] [Abstract][Full Text] [Related]
14. Proton MR spectroscopy of tumefactive demyelinating lesions.
Saindane AM; Cha S; Law M; Xue X; Knopp EA; Zagzag D
AJNR Am J Neuroradiol; 2002 Sep; 23(8):1378-86. PubMed ID: 12223381
[TBL] [Abstract][Full Text] [Related]
15. High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's disease.
Weaver CH; Schwartzberg L; Li W; Hazelton B; West W
Bone Marrow Transplant; 1996 May; 17(5):715-21. PubMed ID: 8733687
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effect of age on treatment-related mortality and relapse in patients with high-risk primary breast cancer receiving high-dose chemotherapy.
Nieto Y; Shpall EJ; Bearman SI; Jones RB
Am J Clin Oncol; 2005 Jun; 28(3):248-54. PubMed ID: 15923796
[TBL] [Abstract][Full Text] [Related]
17. Association of high-dose cyclophosphamide, cisplatin, and carmustine pharmacokinetics with survival, toxicity, and dosing weight in patients with primary breast cancer.
Petros WP; Broadwater G; Berry D; Jones RB; Vredenburgh JJ; Gilbert CJ; Gibbs JP; Colvin OM; Peters WP
Clin Cancer Res; 2002 Mar; 8(3):698-705. PubMed ID: 11895898
[TBL] [Abstract][Full Text] [Related]
18. Fatal chemotherapy-induced encephalopathy following high-dose therapy for metastatic breast cancer: a case report and review of the literature.
Cossaart N; SantaCruz KS; Preston D; Johnson P; Skikne BS
Bone Marrow Transplant; 2003 Jan; 31(1):57-60. PubMed ID: 12621508
[TBL] [Abstract][Full Text] [Related]
19. Hemopoietic recovery and infectious complications in breast cancer and multiple myeloma after autologous CD34+ cell-selected peripheral blood progenitor cell transplantation.
De Rosa L; Anghel G; Pandolfi A; Riccardi M; Amodeo R; Majolino I
Int J Hematol; 2004 Jan; 79(1):85-91. PubMed ID: 14979484
[TBL] [Abstract][Full Text] [Related]
20. Ocular toxicity following high dose chemotherapy and autologous transplant.
Rubin P; Hulette C; Khawly JA; Elkordy M; Hussein A; Vredenburgh JJ; Jaffe GJ; Peters WP
Bone Marrow Transplant; 1996 Jul; 18(1):253-6. PubMed ID: 8832031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
